- Antibodies triggered by China shots less effective on Delta variant
- U.S. approves emergency use of Roche drug for severe COVID-19
- UK could soon lift travel curbs for fully vaccinated people
- WHO estimates annual boosters needed for most vulnerable
- Pfizer, Moderna's 'likely link' to rare heart inflammation